Escalon Medical Corp

Escalon Medical Corp. develops, manufactures, markets, and distributes ophthalmic medical devices and related products for eye-care procedures and diagnostics. Its portfolio includes ultrasound systems for biometric and diagnostic use, disposable surgical packs for vitreoretinal surgery, and the AXIS image management system for ophthalmic imaging workflows.

1,4 %

45,7 %

0,9 %

+0,5 %

1.72

0.92

— Escalon Medical Corp
%
Ophthalmic ultrasound systems45% A-Scan and B-Scan ultrasound devices and related software used for eye diagnostics and biometric measurements.
Ophthalmic surgical disposables35% Disposable surgical packs used in vitreoretinal surgery, including silicone oil handling packs.
Image management software10% AXIS Image Management system for storing and accessing ophthalmic diagnostic images through a web browser.
Service and support10% Repairs, warranties, and remote support for ultrasound, imaging, and surgical products.

Escalon sells primarily to medical institutions and eye-care providers that need diagnostic equipment, surgical...

  • Ophthalmic hospitals and clinicsprimary

    Buy ultrasound systems and image management tools to diagnose and monitor eye conditions.

  • Vitreoretinal surgeonsprimary

    Buy disposable surgical packs and silicone oil handling packs for procedure-specific use.

  • Distributors and independent repssecondary

    Place products into local healthcare markets and expand reach without a large direct field force.

  • Existing installed-base customerssecondary

    Purchase repairs, service, and replacement support for previously installed systems.

Escalon sells throughout the United States and internationally, with 56.0% of fiscal 2025 revenue generated...

  • United States generated 56.0% of fiscal 2025 revenue
  • Foreign markets generated 44.0% of fiscal 2025 revenue
  • New Berlin, Wisconsin handles ophthalmic surgical assembly and distribution
  • Lake Success, New York handles ultrasound design, assembly, and service
  • CE Mark supports sales in Europe and other international markets

Escalon’s strategy centers on refreshing ophthalmic products, supporting its installed base, and using regulatory...

01
Product development and enhancementshort-term

R&D is tied to new and improved ophthalmic products that can drive adoption and offset mature product pressure.

02
International market accessmedium-term

CE Mark and other clearances allow the company to sell beyond the U.S. and diversify demand.

03
Operational support and service retentionmedium-term

Repairs, warranties, and remote support help preserve installed-base relationships and recurring revenue.

Escalon faces meaningful execution and balance-sheet risk because it has a history of operating losses and management...

critical

Going concern and liquidity pressure

The company has a history of operating losses and disclosed substantial doubt about continuing as a going concern.

Scope
Cash to current liabilities and ability to raise capital
Materiality
high
high

Regulatory approval and compliance

Medical devices require FDA and foreign clearances, and changes in rules can delay launches or restrict sales.

Scope
FDA, CE Mark, foreign regulatory approvals
Materiality
high
high

Product liability

Surgical and diagnostic products can create claims if defects or performance issues occur.

Scope
Ophthalmic surgical packs and ultrasound systems
Materiality
medium
high

Customer and supplier concentration

A small number of customers and suppliers can materially affect sales, receivables, and production continuity.

Scope
Top customer and key component vendors
Materiality
high
medium

Cybersecurity and data privacy

The company uses internet-based systems and stores confidential customer and employee data.

Scope
AXIS image management and internal IT systems
Materiality
medium
Revenue mix and timing
Affects quarterly comparability and gross margin
Going concern and liquidity estimates
Can influence disclosures and valuation assumptions
Allowance for doubtful accounts
Affects net revenue and working capital
Inventory and warranty-related estimates
Affects cost of revenue and liabilities
Lease accounting
Affects balance sheet assets and liabilities

: 28.4.2026